je.st
news
The Emperor Is 25% To 65% Naked: Valeant, Salix, And Cash EPS
2015-12-14 19:08:13| Biotech - Topix.net
Valeant's use of Cash EPS for depreciating durable assets seems inappropriate when applied to a finite portfolio of patent products like Salix. Using various depreciation schedules for the debt cost of acquiring Salix lowers VRX's cash EPS from 25% to 65%.
Tags: cash
naked
eps
emperor
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||